---
figid: PMC4688896__nihms744845f1
figlink: /pmc/articles/PMC4688896/figure/F1/
number: F1
caption: Normally, stimulation of cell surface receptors, including NMDA receptors
  (NMDARs) and group 1 metabotropic glutamate receptors (mGluRs; such as mGluR5),
  results in the activation of the phosphoinositide 3-kinase (PI3K),, mammalian target
  of rapamycin complex 1 (mTORC1; which comprises mTOR bound to regulatory-associated
  protein of mTOR (RAPTOR)) and extracellular signal-regulated kinase (ERK)signalling
  pathways in neurons. mTORC1 phosphorylates eukaryotic initiation factor 4E (eIF4E)
  binding proteins (4E-BPs), including 4E-BP2, the predominant 4E-BP isoform in the
  mouse brain, which derepresses eIF4E to promote ‘cap’-dependent translation. mTORC1
  also phosphorylates and activates p70 S6 kinase 1 (S6K1), which phosphorylates ribosomal
  protein S6 and eIF4B. Phosphorylation of eIF4B by S6K1 stimulates the helicase activity
  of eIF4A to promote cap-dependent translation. mTORC1-dependent translation is triggered
  upstream by a signalling pathway involving PI3K, 3-phosphoinositide-dependent protein
  kinase 1 (PDK1) and/or PDK2, AKT, tuberous sclerosis 1 (TSC1) and/ or TSC2 and RAS
  homologue enhanced in brain (RHEB). ERK phosphorylates and activates MAP kinase-interacting
  serine/threonine-protein kinases (MNKs), which phosphorylate eIF4E to promote translation.
  This ERK-dependent translation is triggered upstream by a pathway involving RAS,
  RAF and MAPK/ERK kinase 1 (MEK1). mGluR5 signals to the PI3K–AKT–mTORC1 pathway
  via HOMER1A, SH3 and multiple ankyrin repeat domains (SHANK) proteins and PI3K enhancer
  (PIKE), and NMDARs signal to ERK via postsynaptic density protein 95 (PSD95). The
  protein levels of several targets of the RNA-binding protein fragile X mental retardation
  protein (FMRP), are increased in fragile X syndrome (FXS). The increased expression
  of these proteins results in basally elevated PI3K, mTORC1 and ERK signalling and
  thus increased translation. m7G, 7-methyl-guanosine; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate;
  PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate; UTR, untranslated region.
  Adapted from REF. , Nature Publishing Group.
pmcid: PMC4688896
papertitle: Dysregulation and restoration of translational homeostasis in fragile
  X syndrome.
reftext: Joel D. Richter, et al. Nat Rev Neurosci. ;16(10):595-605.
pmc_ranked_result_index: '167968'
pathway_score: 0.9628292
filename: nihms744845f1.jpg
figtitle: Dysregulation and restoration of translational homeostasis in fragile X
  syndrome
year: ''
organisms:
- Mus musculus
- Drosophila melanogaster
- Gallus gallus
- Homo sapiens
ndex: 634715bb-ded3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4688896__nihms744845f1.html
  '@type': Dataset
  description: Normally, stimulation of cell surface receptors, including NMDA receptors
    (NMDARs) and group 1 metabotropic glutamate receptors (mGluRs; such as mGluR5),
    results in the activation of the phosphoinositide 3-kinase (PI3K),, mammalian
    target of rapamycin complex 1 (mTORC1; which comprises mTOR bound to regulatory-associated
    protein of mTOR (RAPTOR)) and extracellular signal-regulated kinase (ERK)signalling
    pathways in neurons. mTORC1 phosphorylates eukaryotic initiation factor 4E (eIF4E)
    binding proteins (4E-BPs), including 4E-BP2, the predominant 4E-BP isoform in
    the mouse brain, which derepresses eIF4E to promote ‘cap’-dependent translation.
    mTORC1 also phosphorylates and activates p70 S6 kinase 1 (S6K1), which phosphorylates
    ribosomal protein S6 and eIF4B. Phosphorylation of eIF4B by S6K1 stimulates the
    helicase activity of eIF4A to promote cap-dependent translation. mTORC1-dependent
    translation is triggered upstream by a signalling pathway involving PI3K, 3-phosphoinositide-dependent
    protein kinase 1 (PDK1) and/or PDK2, AKT, tuberous sclerosis 1 (TSC1) and/ or
    TSC2 and RAS homologue enhanced in brain (RHEB). ERK phosphorylates and activates
    MAP kinase-interacting serine/threonine-protein kinases (MNKs), which phosphorylate
    eIF4E to promote translation. This ERK-dependent translation is triggered upstream
    by a pathway involving RAS, RAF and MAPK/ERK kinase 1 (MEK1). mGluR5 signals to
    the PI3K–AKT–mTORC1 pathway via HOMER1A, SH3 and multiple ankyrin repeat domains
    (SHANK) proteins and PI3K enhancer (PIKE), and NMDARs signal to ERK via postsynaptic
    density protein 95 (PSD95). The protein levels of several targets of the RNA-binding
    protein fragile X mental retardation protein (FMRP), are increased in fragile
    X syndrome (FXS). The increased expression of these proteins results in basally
    elevated PI3K, mTORC1 and ERK signalling and thus increased translation. m7G,
    7-methyl-guanosine; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate; PtdIns(3,4,5)P3,
    phosphatidylinositol-3,4,5-trisphosphate; UTR, untranslated region. Adapted from
    REF. , Nature Publishing Group.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EIF4B
  - SHANK2
  - GRIN2C
  - MAPK1
  - TSC2
  - MAPK3
  - AKT3
  - TSC1
  - MAP2K2
  - GRM5
  - ATP7A
  - NRAS
  - HRAS
  - KRAS
  - RHEB
  - GRIN1
  - AKT1
  - AKT2
  - EIF4A1
  - FMR1
  - MAP2K1
  - ARAF
  - DLG4
  - RAF1
  - BRAF
  - MTOR
  - GRIN3A
  - GRIN3B
  - EIF4A2
  - GRIN2A
  - GRIN2B
  - EIF4A3
  - PDK2
  - GRIN2D
  - RPTOR
  - PDK1
  - PtdIns(3,4,5)P
  - Glutamate
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: EIF4B
  symbol: EIF4B
  source: hgnc_symbol
  hgnc_symbol: EIF4B
  entrez: '1975'
- word: SHANK
  symbol: SHANK
  source: hgnc_alias_symbol
  hgnc_symbol: SHANK2
  entrez: '22941'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: mGluR5
  symbol: MGLUR5
  source: hgnc_alias_symbol
  hgnc_symbol: GRM5
  entrez: '2915'
- word: MNK
  symbol: MNK
  source: hgnc_prev_symbol
  hgnc_symbol: ATP7A
  entrez: '538'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EIF4A
  symbol: EIF4A
  source: bioentities_symbol
  hgnc_symbol: EIF4A1
  entrez: '1973'
- word: FMRP
  symbol: FMRP
  source: hgnc_alias_symbol
  hgnc_symbol: FMR1
  entrez: '2332'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PSD95
  symbol: PSD-95
  source: hgnc_alias_symbol
  hgnc_symbol: DLG4
  entrez: '1742'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: EIF4A
  symbol: EIF4A
  source: bioentities_symbol
  hgnc_symbol: EIF4A2
  entrez: '1974'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: EIF4A
  symbol: EIF4A
  source: bioentities_symbol
  hgnc_symbol: EIF4A3
  entrez: '9775'
- word: PDK2
  symbol: PDK2
  source: hgnc_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: RAPTOR
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
chemicals:
- word: PtdIns(3,4,5)P
  source: MESH
  identifier: D010716
- word: Glutamate
  source: MESH
  identifier: D018698
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4688896__F1
redirect_from: /figures/PMC4688896__F1
figtype: Figure
---
